GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » MultiPlan Corp (NYSE:MPLN) » Definitions » Days Sales Outstanding

MultiPlan (MultiPlan) Days Sales Outstanding : 30.93 (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is MultiPlan Days Sales Outstanding?

MultiPlan's average Accounts Receivable for the three months ended in Mar. 2024 was $79.5 Mil. MultiPlan's Revenue for the three months ended in Mar. 2024 was $234.5 Mil. Hence, MultiPlan's Days Sales Outstanding for the three months ended in Mar. 2024 was 30.93.

The historical rank and industry rank for MultiPlan's Days Sales Outstanding or its related term are showing as below:

MPLN' s Days Sales Outstanding Range Over the Past 10 Years
Min: 26.63   Med: 28.62   Max: 30.22
Current: 27.79

During the past 6 years, MultiPlan's highest Days Sales Outstanding was 30.22. The lowest was 26.63. And the median was 28.62.

MPLN's Days Sales Outstanding is ranked better than
73.95% of 641 companies
in the Healthcare Providers & Services industry
Industry Median: 46.87 vs MPLN: 27.79

MultiPlan's Days Sales Outstanding increased from Mar. 2023 (28.14) to Mar. 2024 (30.93).


MultiPlan Days Sales Outstanding Historical Data

The historical data trend for MultiPlan's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MultiPlan Days Sales Outstanding Chart

MultiPlan Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial 28.62 27.30 26.63 30.22 29.51

MultiPlan Quarterly Data
Dec18 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.14 26.25 26.16 27.27 30.93

Competitive Comparison of MultiPlan's Days Sales Outstanding

For the Health Information Services subindustry, MultiPlan's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MultiPlan's Days Sales Outstanding Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MultiPlan's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where MultiPlan's Days Sales Outstanding falls into.



MultiPlan Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

MultiPlan's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (78.907 + 76.558) / 2 ) / 961.524*365
=77.7325 / 961.524*365
=29.51

MultiPlan's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding (Q: Mar. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Mar. 2024 )) / count ) / Revenue (A: Mar. 2024 )*Days in Period
=( (76.558 + 82.443) / 2 ) / 234.508*365 / 4
=79.5005 / 234.508*365 / 4
=30.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MultiPlan  (NYSE:MPLN) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


MultiPlan Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of MultiPlan's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


MultiPlan (MultiPlan) Business Description

Traded in Other Exchanges
N/A
Address
115 Fifth Avenue, New York, NY, USA, 10003
MultiPlan Corp is a provider of data analytics and technology-enabled solutions designed to bring affordability, efficiency, and fairness to the U.S. healthcare industry. The company interprets clients' needs and customizes solutions that combine its payment integrity, network-based, and analytics-based services. The Company's focus is being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry.
Executives
John Michael Prince director 115 FIFTH AVE., NEW YORK NY 10003
Nutter Carol officer: SVP, Chief People Officer 115 FIFTH AVE., NEW YORK NY 10003
Anthony Jr Colaluca director MULTIPLAN CORPORATION, 115 FIFTH AVENUE, NEW YORK NY 10003
Mark Tabak director, officer: Chief Executive Officer 115 FIFTH AVENUE, NEW YORK NY 10003
Michael Kim officer: See Remarks POLARIS PARENT CORP, 115 FIFTH AVENUE, NEW YORK NY 10003
Michael K. Attal director 425 PARK AVENUE, 30TH FLOOR, NEW YORK NY 10022
James M Head officer: EVP & Chief Financial Officer 3001 COLORADO BLVD, DENTON TX 76210
Julie D Klapstein director 1239 FRUIT COVE ROAD NORTH, JACKSONVILLE FL 32259
C Martin Harris director
H&f Corporate Investors Viii, Ltd. 10 percent owner 415 MISSION STREET, SUITE 5700, SAN FRANCISCO CA 94105
Music Investments Gp, Llc 10 percent owner C/O HELLMAN & FRIEDMAN, ONE MARTIME PLAZA, 12TH FLOOR, SAN FRANCISCO CA 94111
Music Investments, L.p. 10 percent owner C/O HELLMAN & FRIEDMAN, ONE MARTIME PLAZA, 12TH FLOOR, SAN FRANCISCO CA 94111
Glenn R August director C/O OHA - 1114 AVENUE OF THE AMERICAS, 27TH FLOOR, NEW YORK NY 10036
Paul Galant officer: President, New Markets 88 WEST PLUMERIA DRIVE, SAN JOSE CA 95134
Michael Stuart Klein director, 10 percent owner, officer: Chief Executive Officer C/O DAVIS POLK & WARDWELL, 450 LEXINGTON AVENUE, NEW YORK NY 10017